aTyr Pharma | LIFE - Beban Penjualan Dan Administrasi





Beban Penjualan Dan Administrasi Perubahan Tanggal
Alterity Therapeutics Limited AUD 2.29M 649.1K 2023-06
Ardelyx USD 83.61M 378K 2025-09
aTyr Pharma USD 4.8M 130K 2025-09
Biogen USD 545.2M 38.6M 2025-09
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.33M 50K 2025-09
CSL USD 1.23B 498M 2025-12
Curis USD 4.79M 100K 2024-06
Galapagos EUR 44.42M 9.87M 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
Grifols EUR 333.1M 157M 2025-09
Novartis USD 3.31B 134M 2025-09
Roche Holding CHF 7.28B 3.99B 2025-12
United Therapeutics USD 190.6M 38.6M 2025-12
Xoma USD 11M 2.54M 2024-06